Original news and analysis on international IP policy
The World Intellectual Property Organization has released data on disputes between trademark owners and third parties who are registering new domain names with the original brand name. Disputes are on the rise and the proportion relating to new generic top-level domain names is growing, it found. Fashion and banking are the prominent areas for disputes.
Today in Johannesburg, South Africa, the second of two public dialogues was held by the United Nations Secretary General’s High-Level Panel on Access to Medicines, drawing another packed room and many ideas, experiences and suggestions for solutions.
China, Japan and South Korea are among the top five countries filing international patent applications at the World Intellectual Property Organization, while the United States continues to lead in patent and trademark applications. Far behind, developing countries seem to be having a hard time catching up.
This year will be the last in office for United Nations Secretary General Ban Ki-moon. A number of Eastern European candidates are being proposed by their governments to be the next secretary general. The UN Framework Convention on Climate Change, as well as the UN Environment Programme are expected to have a new head by summer. Meanwhile, chairs are actively revolving in law offices.
An initiative of the United Nations secretary general yesterday gathered what could be described as an assembly of many of the world’s best thinkers and practitioners on public health and intellectual property rights. Industry, activists, academics, international organisations, and possibly some governments poured out their views for nearly seven hours – at times coming to tears and tension – shepherded by an astute moderator, as they responded to the call to take a longstanding debate on medicines access and high prices to a breakthrough.
Today, Médecins Sans Frontières (MSF, Doctors Without Borders) filed a patent opposition against Pfizer’s vaccine for pneumonia in India.
The United States National Institutes of Health’s decision to consider granting an exclusive licence on patents for a newly government-developed vaccine to Sanofi has prompted a strong reaction from civil society warning against potential high prices and requesting transparency in the process.
International experts convened by the World Health Organization this week on the Zika virus said vaccine development is a priority for the future but the most pressing need is to get diagnostic and prevention tools. Over 60 groups are hard at work on experimental products, according to the WHO, while a system of incentives to share virus samples is being considered.
The United Nations Secretary General’s High-Level Panel on Access to Medicines is holding a global dialogue this month, attended by governments, civil society, industry and academia, to discuss potential solutions to promote innovation and at the same time increase access to medicines. The first public dialogue session is this week, on 10 March in London.
The World Health Organization said today that evidence of the relationship between the Zika virus and neonatal malformations and neurological disorders is growing stronger. The Emergency Committee set up by the WHO at a gathering today issued advice to the WHO director general, including warning pregnant women to avoid travelling to Zika infected countries. Meanwhile, discussions are ongoing on the sharing of the samples of the virus, and on the question of benefit-sharing. And a call was made for research and development to intensify.